Person:
ZENGİN KURT, BELMA

Loading...
Profile Picture
Status
Organizational Units
Job Title
First Name
BELMA
Last Name
ZENGİN KURT
Name
Email Address
Birth Date

Search Results

Now showing 1 - 2 of 2
No Thumbnail Available
PublicationMetadata only

Synthesis of flurbiprofen thiadiazole urea derivatives and assessment of biological activities and molecular docking studies

2023-01-01, ZENGİN KURT B., Altundağ Ö., Tokgöz M. N., ÖZTÜRK CİVELEK D., Tuncay F. O., Cakmak U., KOLCUOĞLU Y., Akdemir A., Sönmez F., ZENGİN KURT, BELMA, ÖZTÜRK CİVELEK, DİLEK

Totally 15 novel flurbiprofen urea derivatives were synthesized bearing the thiadiazole ring. Their inhibition effects on tyrosinase were determined. 3c was found to be the strongest inhibitor with the IC50 value of 68.0 μM against tyrosinase. The enzyme inhibition types of the synthesized compounds were determined by examining the kinetic parameters. The inhibition type of 3c was determined as uncompetitive and the Ki value was calculated as 36.3 μM. Moreover, their cytotoxic effects on hepatocellular carcinoma (HepG2), colorectal carcinoma (HT-29), and melanoma (B16F10) cell lines were evaluated. According to the cytotoxicity results, 3l (IC50 = 14.11 μM) showed the highest cytotoxicity on the HT-29 cells, while 3o (IC50 = 4.22 μM) exhibited the strongest cytotoxic effect on HepG2 cell lines. Also, 3j (IC50 = 7.55 μM strongly affected B16F10. The effects of synthesized compounds on the healthy cell line were evaluated on the CCD-986Sk cell line. Molecular modelling studies have indicated the potential binding interactions of the uncompetitive inhibitor 3c with the enzyme-substrate complex.

No Thumbnail Available
PublicationMetadata only

Synthesis of Sorafenib−Ruthenium Complexes, Investigation of Biological Activities and Applications in Drug Delivery Systems as an Anticancer Agent

2024-03-01, Zengin Kurt B., Öztürk Civelek D., Çakmak E. B., Kolcuoğlu Y., Şenol H., Sağlık Özkan B. N., Dağ A., Benkli K., ZENGİN KURT, BELMA, ÖZTÜRK CİVELEK, DİLEK, ŞENOL, HALIL, DAĞ, AYDAN